
Life-changing mental health therapies without a
lifetime of development
Questors Precision Medicine solves the most complex mental health clinical development challenges to bring innovative therapies to patients.
Questors private public sector partnership for mental health is working to help patients in need should be subjected to unnecessary delays during clinical development and commercialization. Questors Precision’ Technology Crypta's integrated capabilities, responsive operations and deep scientific expertise are helping life science innovators accelerate research and development while reducing cost and increasing the probability of approval.
Specialized capabilities for every stage of clinical development
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Questors Precision brings a holistic view to your program's unique needs.

Global CRO Services

Global Laboratory Services

Biospecimens

Diagnostics & CDx

Data Intelligence

Commercialization
THE APPROVED
TREATMENT FOR
EFFICIENT MANAGEMENT
Questors is a right-sized CRO and the antidote to the widespread efficient R&D result analytics that can come from dealing with a shared platform with CRO. We specialize in the unique needs of complex trials. Our people are assigned to no more than 2 or 3 trials at a time, so you get the attention you need, when you need it. Find out more about how Questors Precision Analytics brings efficient reportings.


How can you successfully navigate the complexities of early phase development? Integrated clinical and laboratory sciences capabilities are vital. Over 25 years of experience in early oncology development helps anticipate and mitigate a diverse set of risks, including complicated kitting and sample management.
Optimize early phase development

​Congratulations if you are entering late phase development. Now you'll need a partner that can recruit patients most likely to respond to treatment, manage complex protocols, anticipate global regulatory requirements, enable manufacturing, support commercial viability and more. Let us drive your innovation to market and empower access for patients.
Maximize late phase development

Trusted partner to leading innovators in mental health and rare neglected disease
Clinical development is growing more complicated. Progress can hinge on the ability to navigate a shifting pathway to approval. Your path may be unique from those who have gone before, but our experience will help inform success. Questors Precision is a leader in mental health and rare neglected disease research. Our deep experience in complex indications accelerates the ability to reach key milestones, drive positive outcomes and most importantly, help patients get access to innovative treatments.
70%
of clinical trials are in Mental Health
200+
clinical trial and lab projects
6
Regional partnership in specialty labs in the US and Europe
$30B
in investments raised for biotech in the last 5 years
Winner of the 2025 Biotech CRO Award for Innovative Solutions in Drug Development
& Pharmacovigilance
Precision is dedicated to operational excellence and our collaborative approach to tackling complex challenges mental health and rare neglected disease research.
This recognition highlights our successful rescue of a high-risk OUD/SUD poly drug anti-addiction therapeutics trial, where we conducted a full operational and data gap analysis, rebuilt sponsor alignment through proactive collaboration, implemented centralized patient-level data monitoring, and developed custom tracking systems to accelerate regulatory and startup activities.
We’re proud to help advance critical therapies and grateful to the sponsors, investigators, and teams who make this work possible.

AI ML Driven prediction for pre-clinical and clinical data integration
Deep learning for experience with debilitating mental health disease
and unique modalities
Like you, we understand that there’s a patient throughout the development pathway. Supporting our partners to bring innovative treatments to patients is our purpose. Leverage our experience in these therapeutic areas.
Mental Health
​
.webp)
Tropical Diseases
.webp)
Rare Neglected
Diseases
.webp)
Infectious
Diseases
.webp)
Autoimmune
.webp)
​The conversion of manualized reporting platfom Crypta
Excel sample tracking to automated QuartzBio reporting resulted in 70% resource saving and shortened study and site close timeline by weeks.
Director, Top 20 Pharma Client
Questors Precision Medicine has been a clinical research partner in identifying the right clinical partners, doctors, the right patients, and collect all the data that will be necessary to analyze, to be able to unequivocally answer the question of safety and dose
Chief Medical Officer, Biotech Company
Questors experienced and qualified staff displayed resiliency, creativity and innovation to keep things moving in the face of huge obstacles.
Director, Mental Health & Psychedleically Assiisted Therapy/ Medically Assisted Therapy
I recognize that relations between Sponsors and CRO partners with Questors CTMS and Reporting to the Ibogaine and psychedelic mental health therapeutic clinical trial reporting on a hyperledger can bring greater fcilittation forr strategic and difficult, regulatory apprroval transparency to the new frontier of entheogens has never been my experience with this group as it truly felt like a partnership.
Director, Small Biotech
Insights for the greater health equity
We feel privileged to work in an industry that can change lives. When knowledge is shared, it is amplified. Expanding our collective intelligence can bring remedies to market faster.

Reflect on 50 Years of Mental Health Research with Challenges of Legislation and Advocacy
MyungHi S. Lee

Biomarker-Driven Clinical Trials in Mental Health: Enrichment, Stratification, Analytical Prediction Medical Research
S. Lee

Lost in Translation: Turning Multi-omic Chaos into Clinical Clarity
Jeffrey G. Johnson Ph D

Life sciences innovators come to Questors Precision
to bring life-changing medicine to patients.
How can we help you?

